MedPath

SR-878

Generic Name
SR-878

Study Investigating the Safety, Tolerability and Blood Concentration of the Substance SR-878

Phase 1
Recruiting
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2024-09-23
Last Posted Date
2024-12-02
Lead Sponsor
SciRhom GmbH
Target Recruit Count
48
Registration Number
NCT06607484
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath